Creighton University School of Medicine, Omaha, NE, USA.
Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, 500 W. Thomas Road, Ste. 500, Phoenix, AZ, 85013, USA.
J Gastrointest Surg. 2018 Feb;22(2):177-186. doi: 10.1007/s11605-017-3480-4. Epub 2017 Jul 5.
Some patients require one or more reoperative interventions after undergoing primary antireflux surgery (ARS). We compared outcomes after primary and reoperative ARS.
We queried a prospectively maintained database to identify patients who underwent ARS from September 23, 2003 to May 28, 2016. Patients were categorized into four groups: A (primary ARS), B (first reoperative ARS), C (second reoperative ARS), or D (≥ third reoperative ARS). Patients completed follow-up foregut symptom surveys and satisfaction questionnaires at regular intervals.
In total, 940 patients were studied (A: n = 545, B: n = 302, C: n = 80, D: n = 13). Age, sex, and BMI were comparable across groups. Heartburn was the most common preoperative symptom in A, whereas dysphagia was more common in B-D. Open approach, mean operative time, and mean blood loss increased from A to D (P < 0.05), as did need for Roux-en-Y reconstruction. Vagal injury (2-19-33-54%; P < 0.05), visceral perforation (2-20-36-23%; P < 0.05), postoperative leak (0.2-2-6-8%; P < 0.05 A vs. all), and morbidity (2-10-14-39%; P < 0.05) also increased from A to D. At mean follow-up of 36 months, the proportion of patients who reported no significant symptoms, excellent satisfaction, and likeliness to recommend this surgery to a friend progressively declined with each successive reintervention (P < 0.05).
Complications and patient-reported outcomes worsen with each reoperative ARS.
一些患者在接受初次抗反流手术(ARS)后需要一次或多次再次手术干预。我们比较了初次和再次 ARS 的结果。
我们查询了一个前瞻性维护的数据库,以确定 2003 年 9 月 23 日至 2016 年 5 月 28 日期间接受 ARS 的患者。患者分为四组:A(初次 ARS)、B(初次再次 ARS)、C(第二次再次 ARS)或 D(≥第三次再次 ARS)。患者定期完成上消化道症状调查和满意度问卷。
共有 940 例患者接受了研究(A:n=545,B:n=302,C:n=80,D:n=13)。年龄、性别和 BMI 在各组之间无差异。A 组最常见的术前症状是烧心,而 B-D 组则更常见吞咽困难。开放入路、平均手术时间和平均失血量从 A 组增加到 D 组(P<0.05),Roux-en-Y 重建的需求也增加。迷走神经损伤(2-19-33-54%;P<0.05)、内脏穿孔(2-20-36-23%;P<0.05)、术后漏(0.2-2-6-8%;P<0.05 A 与所有)和发病率(2-10-14-39%;P<0.05)也从 A 组增加到 D 组。在平均 36 个月的随访中,报告无明显症状、非常满意和愿意向朋友推荐此手术的患者比例随着每次再次手术干预而逐渐下降(P<0.05)。
每次再次 ARS 都会增加并发症和患者报告的结果恶化。